| Excerpt | Relevance | Reference |
|---|
| "Another pandemic disease is type II diabetes mellitus (T2D) that is estimated to affect half a billion people in the world." | 5.62 | 16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment. ( Baay-Guzman, G; Barrios-Payan, JA; Bini, E; Carranza, A; Chamberlin, W; Ge, Y; Hernández-Pando, R; López-Torres, MO; Marquina-Castillo, B; Mata-Espinosa, D; Ramos-Espinosa, O; Torre-Villalvazo, I; Torres, N; Tovar, A; Yepez, SH, 2021) |
| "Another pandemic disease is type II diabetes mellitus (T2D) that is estimated to affect half a billion people in the world." | 1.62 | 16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment. ( Baay-Guzman, G; Barrios-Payan, JA; Bini, E; Carranza, A; Chamberlin, W; Ge, Y; Hernández-Pando, R; López-Torres, MO; Marquina-Castillo, B; Mata-Espinosa, D; Ramos-Espinosa, O; Torre-Villalvazo, I; Torres, N; Tovar, A; Yepez, SH, 2021) |